ABIDer

I'm interested in hearing if other labs have a delta check set up for INRs. If so, what is the delta and for what time interval.

The Ortho fetalscreen kit states "The maternal blood should be collected as soon as possible after delivery." Our policy states 1-3 hours after delivery and the order defaults to "Stat".

We have a provider who wants all of her pregnant women to have a repeat antibody screen sometime during the second trimester. I've never heard of anyone doing this on a routine basis. Has anyone else had this request? Thanks

Thank you all very much for your replies. This has helped, greatly. I was leaning towards the "new type/admission" process, initially, and it looks like that's what many of you are doing. We have a patient population who have been known to swap identifications which is why I don't feel comfortable relying on historical typings.

I am trying to determine the frequency that other transfusion services perform ABO testing on their recipients prior to FFP transfusion? Do you perform a new type if more than 3 days have elapsed? What about with a new admission? If the patient has at least two previous blood types, do you still do another one prior to transfusing that patient even though it's a new admission? Thanks in advance for your comments.

The question is whether to continue to monitor the patient once the transfusion has ended or just let them go with a list of "reactions" to watch out for. We also follow the patients closely throughout the transfusion but we also like to check again, one hour post transfusion. Do you check vitals any time after the transfusion has ended?

I realize this is an old thread but we are currently evaluating our post transfusion patient observation time at our hospital. We check vitals at one hour post transfusion for all of our patients. We are being asked, by nursing, to disregard this post check for out-patient transfusions at our infusion site. We would like to know what others are doing for all transfusion recipients and whether any distiction is made between in-patients and out-patients at your institutions.

Ours are very similar to yours. EPI: 80-184 ADP 56-102

I know this is an old thread but we are now in the same boat as Jody. Has anyone ever used Cerner for validation of their own system? I'm not sure how I feel about that and am interested in hearing what others think. We will be doing extensive unit testing ourselves but we want a third party for anything that may get overlooked. Thanks in advance.

Are the techs diluting the 3% Panocells when using gel? They may be using Liss in tube since 0.8% is needed for gel. Do you a 0.8% panel?

I will be there as well and would love to meet all of you. Hopefully we can find each other. I don't have a red hat but maybe we can come up with signs that say BBTALK like they do at the airports See ya'll soon!

Thanks for your replies. I guess we will stick to quarterly like it has in the Technical manual but I do think it's a bit much. That's just my opinion.

I don't know if this has been discussed before but I'm interested in hearing everyone's comments. Many transfusion services verify the accuracy of their pipettes twice a year but the technical manual says to do it quarterly. What are the majority of you doing? Thanks

Does anyone have a good procedure for Mixing Studies that you are willing to share? I do not like the one we currently have and I can't seem to find any references for one. Thanks

Can anyone give me a resource to show that routine ABO testing of baby's from O moms is not necessary and a waste of money? I have to produce evidence as to why we are not doing it and why we don't need to be and I need it quickly. Any help is appreciated. Thanks :mad: